Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vivus Stock Jumps 12.5% On Drug Approval
Investors.com
Wednesday, July 18, 2012 - 12:14pm
tags:
Vivus, approval, Qnexa, Qsymia, obesity
InterMune Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Wednesday, July 18, 2012 - 12:13pm
tags:
earnings, InterMune
No Tears For Johnson & Johnson, Still Remarkable
Seeking Alpha
Wednesday, July 18, 2012 - 12:10pm
tags:
JNJ, earnings
Novo faces new hurdle in long-acting insulin race
Reuters
Wednesday, July 18, 2012 - 11:52am
tags:
Novo Nordisk, degludec, long-acting insulin
Abbott Labs net declines; year outlook affirmed
Marketwatch
Wednesday, July 18, 2012 - 10:59am
tags:
Abbott Laboratories, earnings
U.S. FDA approves Vivus weight-loss pill Qsymia
Reuters
Tuesday, July 17, 2012 - 10:31pm
tags:
FDA, obesity, Vivus, Qsymia, Qnexa
Vivus Weight-Loss Pill Approved -- Maybe?
TheStreet.com
Tuesday, July 17, 2012 - 5:56pm
tags:
Vivus, Qnexa, obesity, Qsymia
Biogen, Bayer Drugs Don’t Slow MS Progress, Study Finds
Bloomberg
Tuesday, July 17, 2012 - 5:53pm
tags:
BiogenIdec, Bayer, MS, multiple sclerosis, beta interferon
Somaxon settles Silenor litigation with Mylan and PAR
Yahoo
Tuesday, July 17, 2012 - 4:21pm
tags:
Silenor, Mylan, Par Pharmaceutical, Somaxon
Amicus Therapeutics and GlaxoSmithKline Expand Fabry Disease Collaboration
Yahoo
Tuesday, July 17, 2012 - 4:17pm
tags:
GSK, Amicus Therapeutics, Fabry's disease
US says busts $108 mln black market in Medicaid drugs
Reuters
Tuesday, July 17, 2012 - 4:15pm
tags:
Medicaid
Forest Labs Net Falls On Generic Competition To Lexapro
Bloomberg
Tuesday, July 17, 2012 - 12:35pm
tags:
earnings, Forest Labs
Merck stock hits new 52-week high
TheStreet.com
Tuesday, July 17, 2012 - 12:28pm
tags:
Merck
Gilead Faces Big Issues With AIDS Vaccine
Seeking Alpha
Tuesday, July 17, 2012 - 12:22pm
tags:
Truvada, HIV, AIDS, Gilead, vaccines
StemCells rockets 40% on Alzheimer's study
Marketwatch
Tuesday, July 17, 2012 - 12:18pm
tags:
Alzheimer's disease, StemCells
Baxter Alzheimer's drug keeps four patients stable for 3 years
Reuters
Tuesday, July 17, 2012 - 11:54am
tags:
Baxter, Alzheimer's disease, Gammagard
Teva/Active Biotech MS pill accepted for review in Europe
Pharma Times, UK
Tuesday, July 17, 2012 - 11:43am
tags:
Teva Pharmaceuticals, Active Biotech, MS, multiple sclerosis, Europe
Diet drug makers Vivus and Orexigen fall ahead of FDA decision
Reuters
Tuesday, July 17, 2012 - 11:27am
tags:
Vivus, Orexigen, Contrave, obesity, Qnexa
Alnylam Pushes Forward In Amyloidosis After Pfizer Setback
Seeking Alpha
Tuesday, July 17, 2012 - 11:08am
tags:
Alnylam, amyloidosis, Pfizer, ALN-TTR02
Transition Therapeutics Awaiting Competing AD Trial Results
Seeking Alpha
Tuesday, July 17, 2012 - 10:48am
tags:
Transition Therapeutics, Elan, JNJ, Eli Lilly, Pfizer, Alzheimer's disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.